About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Infection and Immunity in pediatric patients research group is a multidisciplinary pediatric research group made up of health professionals involved in translational research in the field of pediatric infectious diseases and immunodeficiencies, two related fields in terms of pathophysiology and clinical implications. It is a consolidated research group recognized by the AGAUR and is the only one with the accreditation of the Jeffrey Modell Foundation in research in the field of primary immunodeficiencies throughout the state.
The group was officially created in 2010, belongs to the area of Infectious Diseases and participates in the transversal programs of Advanced Translational Immunology and Rare Diseases and actively participates in national and international competitive projects, carries out multiple academic and industry-linked clinical trials and has increased the number and quality in recent years. In addition, it has its own laboratory specially dedicated to advanced immune studies.
PMID: 36704126 Journal: Frontiers in Pediatrics Year: 2022 Reference: Front Pediatr. 2023 Jan 10;10:1099305. doi: 10.3389/fped.2022.1099305. eCollection 2022. Impact factor: Publication type: Letter whit IF Authors: Cabanas Poy, Maria Jose; Frick, Marie Antoinette; Hernandez-Perez, Susana; Parramon-Teixido, Carlos Javier; Puertas Sanjuan, Adrian et al. DOI: 10.3389/fped.2022.1099305
PMID: 35120649 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2022 Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):51-52. doi: 10.1016/j.eimce.2021.12.007. Impact factor: 1.731 Publication type: Editorail in international publication Authors: Fernandez-Polo, Aurora; Soler-Palacin, Pere et al. DOI: 10.1016/j.eimce.2021.12.007
PMID: 35120651 Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA Year: 2022 Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Feb;40(2):59-65. doi: 10.1016/j.eimce.2021.05.012. Impact factor: 1.731 Publication type: Paper in international publication Authors: Villanueva-Bueno, Cristina; Montecatine-Alonso, Elena; Jimenez-Parrilla, Francisco; Fernandez-Llamazares, Cecilia M; Manrique-Rodriguez, Silvia; Zamora-Flores, Elena; Dolz, Elisenda; Fernandez-Polo, Aurora; Catillo-Salinas, Felix; Comunas, Juanjo et al. DOI: 10.1016/j.eimce.2021.05.012
PMID: 35134165 Journal: CLINICAL INFECTIOUS DISEASES Year: 2022 Reference: Clin Infect Dis. 2022 Jan 20. pii: 6520762. doi: 10.1093/cid/ciab928. Impact factor: 9.079 Publication type: Paper in international publication Authors: Shaheen, Shareef; Hayden, Randall; Suganda, Sri; Zaoutis, Theoklis E; Chang, Yeh-Chung; Yin, Dwight E; Huppler, Anna R; Danziger-Isakov, Lara; Muller, William J; Roilides, Emmanuel et al. DOI: 10.1093/cid/ciab928
PMID: 33462728 Journal: JOURNAL OF CLINICAL IMMUNOLOGY Year: 2021 Reference: J Clin Immunol. 2021 May;41(4):748-755. doi: 10.1007/s10875-020-00961-w. Epub 2021 Jan 18. Impact factor: Publication type: Paper in international publication Authors: Alonso, Laura; Bueno, David; de Paz, Raquel; Diaz de Heredia, Cristina; Gimeno, Ramon; Lopez-Granados, Eduardo; Mendez-Echevarria, Ana; Mozo, Yasmina; Perez-Martinez, Antonio; Querol, Sergi et al. DOI: 10.1007/s10875-020-00961-w
PMID: 33352085 Journal: EMERGING INFECTIOUS DISEASES Year: 2021 Reference: Emerg Infect Dis. 2021 Jan;27(1). doi: 10.3201/eid2701.190782. Impact factor: Publication type: Review in international publication Authors: Abdala, Edson; Aguado, Jose Maria; Alastruey-Izquierdo, Ana; Campos-Herrero, Maria Isolina; Castro-Mendez, Carmen; Costa-Mateo, Jose Maria; de Pipaon, Maite Ruiz Perez; Fernandez-Ruiz, Mario; Fortun, Jesus; Garcia-Lozano, Tomas et al. DOI: 10.3201/eid2701.190782
PMID: 34155260 Journal: Scientific Reports Year: 2021 Reference: Sci Rep. 2021 Jun 21;11(1):12940. doi: 10.1038/s41598-021-92381-y. Impact factor: Publication type: Paper in international publication Authors: Arostegui, Juan I; Batlle-Maso, Laura; Bonet, Nuria; Casals, Ferran; Lobon, Irene; Marques-Bonet, Tomas; Mensa-Vilaro, Anna; Solis-Moruno, Manuel et al. DOI: 10.1038/s41598-021-92381-y
PMID: 34748988 Journal: Travel Medicine and Infectious Disease Year: 2021 Reference: Travel Med Infect Dis. 2021 Nov-Dec;44:102196. doi: 10.1016/j.tmaid.2021.102196. Epub 2021 Nov 5. Impact factor: 6.211 Publication type: Paper in international publication Authors: Comelli, Agnese, Guarner, Maria Espiau, Tomasoni, Lina Rachele, Zamboni, Agnese Fanetti, Pavon, Belen Moreno, Zanotti, Paola, Caligaris, Silvio, Matteelli, Alberto, Soriano-Arandes, Antoni, Castelli, Francesco et al. DOI: 10.1016/j.tmaid.2021.102196
The study seeks to better understand blood disorders in children and young people, analyzing the role of immunological alterations to improve diagnosis and treatment.
Members of the RBDCOV project, which involves VHIR, gathered at the Palau Macaya to review progress and achievements made during the final phase of the project.
During the meeting, the role of the Vall d'Hebron Paediatric Research Hub in promoting research on children and adolescents was highlighted.
